255 related articles for article (PubMed ID: 23045520)
1. Child Neurology: a case of PMM2-CDG (CDG 1a) presenting with unusual eye movements.
Coorg R; Lotze TE
Neurology; 2012 Oct; 79(15):e131-3. PubMed ID: 23045520
[No Abstract] [Full Text] [Related]
2. [Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].
Sätilä H; Kuusela AL; Pietilä K; Niinikoski H; Keskinen P
Duodecim; 2016; 132(3):253-9. PubMed ID: 26951030
[TBL] [Abstract][Full Text] [Related]
3. PMM2-CDG: phenotype and genotype in four affected family members.
Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
[TBL] [Abstract][Full Text] [Related]
4. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate-deficient glycoconjugate (CDG) syndromes: a new chapter of neuropaediatrics.
Jaeken J; Casaer P
Eur J Paediatr Neurol; 1997; 1(2-3):61-6. PubMed ID: 10728197
[No Abstract] [Full Text] [Related]
6. Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment.
Serrano M; de Diego V; Muchart J; Cuadras D; Felipe A; Macaya A; Velázquez R; Poo MP; Fons C; O'Callaghan MM; García-Cazorla A; Boix C; Robles B; Carratalá F; Girós M; Briones P; Gort L; Artuch R; Pérez-Cerdá C; Jaeken J; Pérez B; Pérez-Dueñas B
Orphanet J Rare Dis; 2015 Oct; 10():138. PubMed ID: 26502900
[TBL] [Abstract][Full Text] [Related]
7. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype.
Monin ML; Mignot C; De Lonlay P; Héron B; Masurel A; Mathieu-Dramard M; Lenaerts C; Thauvin C; Gérard M; Roze E; Jacquette A; Charles P; de Baracé C; Drouin-Garraud V; Khau Van Kien P; Cormier-Daire V; Mayer M; Ogier H; Brice A; Seta N; Héron D
Orphanet J Rare Dis; 2014 Dec; 9():207. PubMed ID: 25497157
[TBL] [Abstract][Full Text] [Related]
8. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
[TBL] [Abstract][Full Text] [Related]
9. The Analysis of Variants in the General Population Reveals That
Citro V; Cimmaruta C; Monticelli M; Riccio G; Hay Mele B; Cubellis MV; Andreotti G
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061496
[TBL] [Abstract][Full Text] [Related]
10. PMM2-CDG and sensorineural hearing loss.
Kasapkara ÇS; Barış Z; Kılıç M; Yüksel D; Keldermans L; Matthijs G; Jaeken J
J Inherit Metab Dis; 2017 Sep; 40(5):629-630. PubMed ID: 28762107
[No Abstract] [Full Text] [Related]
11. Congenital Disorder of Glycosylation (CDG) Presenting as Non-immune Hydrops Fetalis.
Panigrahy N; Lingappa L; Ramadevi AR; Venkatlakshmi A
Indian J Pediatr; 2016 Apr; 83(4):359-60. PubMed ID: 26365158
[No Abstract] [Full Text] [Related]
12. From gestalt to gene: early predictive dysmorphic features of PMM2-CDG.
Martinez-Monseny A; Cuadras D; Bolasell M; Muchart J; Arjona C; Borregan M; Algrabli A; Montero R; Artuch R; Velázquez-Fragua R; Macaya A; Pérez-Cerdá C; Pérez-Dueñas B; Pérez B; Serrano M;
J Med Genet; 2019 Apr; 56(4):236-245. PubMed ID: 30464053
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.
Medrano C; Vega A; Navarrete R; Ecay MJ; Calvo R; Pascual SI; Ruiz-Pons M; Toledo L; García-Jiménez I; Arroyo I; Campo A; Couce ML; Domingo-Jiménez MR; García-Silva MT; González-Gutiérrez-Solana L; Hierro L; Martín-Hernández E; Martínez-Pardo M; Roldán S; Tomás M; Cabrera JC; Mártinez-Bugallo F; Martín-Viota L; Vitoria-Miñana I; Lefeber DJ; Girós ML; Serrano Gimare M; Ugarte M; Pérez B; Pérez-Cerdá C
Clin Genet; 2019 May; 95(5):615-626. PubMed ID: 30653653
[TBL] [Abstract][Full Text] [Related]
14. Thyroid function in PMM2-CDG: diagnostic approach and proposed management.
Mohamed M; Theodore M; Claahsen-van der Grinten H; van Herwaarden AE; Huijben K; van Dongen L; Kouwenberg D; Lefeber DJ; Wevers RA; Morava E
Mol Genet Metab; 2012 Apr; 105(4):681-3. PubMed ID: 22386715
[TBL] [Abstract][Full Text] [Related]
15. Congenital disorders of glycosylation with neonatal presentation.
Resende C; Carvalho C; Alegria A; Oliveira D; Quelhas D; Bandeira A; Proença E
BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24739649
[TBL] [Abstract][Full Text] [Related]
16. Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG.
Thompson DA; Lyons RJ; Russell-Eggitt I; Liasis A; Jägle H; Grünewald S
J Inherit Metab Dis; 2013 Nov; 36(6):1039-47. PubMed ID: 23430200
[TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinaemic hypoglycaemia--leading symptom in a patient with congenital disorder of glycosylation Ia (phosphomannomutase deficiency).
Böhles H; Sewell AA; Gebhardt B; Reinecke-Lüthge A; Klöppel G; Marquardt T
J Inherit Metab Dis; 2001 Dec; 24(8):858-62. PubMed ID: 11916319
[TBL] [Abstract][Full Text] [Related]
18. Genotypes and estimated prevalence of phosphomannomutase 2 deficiency in Turkey differ significantly from those in Europe.
Yıldız Y; Arslan M; Çelik G; Kasapkara ÇS; Ceylaner S; Dursun A; Sivri HS; Coşkun T; Tokatlı A
Am J Med Genet A; 2020 Apr; 182(4):705-712. PubMed ID: 31981409
[TBL] [Abstract][Full Text] [Related]
19. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).
Grünewald S
Biochim Biophys Acta; 2009 Sep; 1792(9):827-34. PubMed ID: 19272306
[TBL] [Abstract][Full Text] [Related]
20. Renal involvement in PMM2-CDG, a mini-review.
Altassan R; Witters P; Saifudeen Z; Quelhas D; Jaeken J; Levtchenko E; Cassiman D; Morava E
Mol Genet Metab; 2018 Mar; 123(3):292-296. PubMed ID: 29229467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
